Viewing Study NCT01206361


Ignite Creation Date: 2025-12-24 @ 11:48 AM
Ignite Modification Date: 2026-01-31 @ 5:54 AM
Study NCT ID: NCT01206361
Status: COMPLETED
Last Update Posted: 2021-02-02
First Post: 2010-08-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Real World Data Study Assessing The Persistency Of Xalacom And The Other Fixed Dose Combination Products, Duotrav And Ganfort, In The United Kingdom
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glaucoma View
None Ocular Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Real world View
None observational View
None retrospective View
None database analysis View